Home
About
Overview
Sharing Data
ORCID
Help
History (59)
Cole, Naida
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
Short (= 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.
Oxidative reactive species in cell injury: Mechanisms in diabetes mellitus and therapeutic approaches.
Rethinking high-risk neuroblastoma treatment.
See All 59 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rethinking high-risk neuroblastoma treatment.
Rethinking high-risk neuroblastoma treatment. Pediatr Blood Cancer. 2022 08; 69(8):e29730.
View in:
PubMed
subject areas
Disease-Free Survival
Humans
Neuroblastoma
authors with profiles
Susan Cohn